Astrana Health expects material weakness in internal controls; 10-K filing by extension deadline

Astrana Health, Inc.

Updated investor presentation furnished; no specific new financial or strategic details.
Forward-looking statements disclose expected material weakness in internal control over financial reporting for FY2025.
Company expects to file 2025 Form 10-K on or before extended due date following Form 12b-25.
Warns that financial statements in 10-K may differ from prior earnings release information.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.